Jeanne Thoma

CIK: 0001819879

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (37.5%)

Position reduction

Option Exercises (M)1 (12.5%)

Derivative conversions

Awards (A)3 (37.5%)

Compensation grants

Other (G, F, J, C, D, …)1 (12.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ANIP

ANI PHARMACEUTICALS INC

Director

CDMO

Avid Bioservices, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

ANIP
ANI PHARMACEUTICALS INC
Sep 11, 2026
Sale(S)
Direct
1K shares at avg. $71.53$72K
ANIP
ANI PHARMACEUTICALS INC
May 21, 2026
Award(A)
Direct
4.4K shares-
ANIP
ANI PHARMACEUTICALS INC
Aug 18, 2025
Sale(S)
Direct
14.7K shares at avg. $88.87$1.3M
ANIP
ANI PHARMACEUTICALS INC
Aug 18, 2025
Sale(S)
Direct
6.9K shares at avg. $89.76$616K
ANIP
ANI PHARMACEUTICALS INC
May 22, 2025
Award(A)
Direct
4.3K shares-
CDMO
Avid Bioservices, Inc.
Feb 5, 2025
Disposition(D)
Direct
45.6K shares-
CDMO
Avid Bioservices, Inc.
Dec 14, 2024
Exercise(M)
Direct
26.8K shares-
CDMO
Avid Bioservices, Inc.
Dec 14, 2024
Award(A)
Restricted Stock Units
Direct
8.1K shares-

		Type	Shares	Price		Ownership
Sep 11, 2026	ANIP ANI PHARMACEUTICALS INC	Sale(S)	1,000	$71.53	$71,530	Direct
May 21, 2026	ANIP ANI PHARMACEUTICALS INC	Award(A)	4,357	-	$0	Direct
Aug 18, 2025	ANIP ANI PHARMACEUTICALS INC	Sale(S)	14,675	$88.87	$1,304,167	Direct
Aug 18, 2025	ANIP ANI PHARMACEUTICALS INC	Sale(S)	6,865	$89.76	$616,202	Direct
May 22, 2025	ANIP ANI PHARMACEUTICALS INC	Award(A)	4,336	-	-	Direct
Feb 5, 2025	CDMO Avid Bioservices, Inc.	Disposition(D)	45,611	-	-	Direct
Dec 14, 2024	CDMO Avid Bioservices, Inc.	Exercise(M)	26,756	-	$0	Direct
Dec 14, 2024	CDMO Avid Bioservices, Inc.	Award(A) Restricted Stock Units	8,147	-	-	Direct

1-8 of 8 transactions

About Thoma Jeanne

Thoma Jeanne (SEC CIK 0001819879) files insider reports with the SEC as Director of ANI PHARMACEUTICALS INC (ANIP) and Director of Avid Bioservices, Inc. (CDMO).

Signal8 holds 6 ownership filings by Thoma Jeanne, all Form 4s, filed between Dec 17, 2024 and Sep 14, 2026. Those filings report 8 transactions, from Dec 14, 2024 to Sep 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Thoma Jeanne's filings is in PRINCETON, NJ.

Recent filings by Thoma Jeanne

Sep 11, 2026: Open-market sale of ANIP shares (Form 4, code S).
May 21, 2026: Grant or award of ANIP shares (Form 4, code A).
Aug 18, 2025: Open-market sales of ANIP shares (2 lines, Form 4, code S).
May 22, 2025: Grant or award of ANIP shares (Form 4, code A).
Feb 5, 2025: Disposition to issuer transaction of CDMO shares (Form 4, code D).

Other insiders filing for ANI PHARMACEUTICALS INC (ANIP)

CAREY STEPHEN P., SVP & CFO
Lalwani Nikhil, PRESIDENT & CEO
Cook Meredith, SR. VP, GENERAL COUNSEL & SEC.
Gosebruch Henry O, Director
Gutwerg Ori, SVP, GENERICS
TANNENBAUM RENEE P, Director

How to read Form 4 transaction codes